US Chamber Loses Bid to Revive Lawsuit on Drug Price Talks (1)

The US Chamber of Commerce and affiliates suffered a loss Wednesday after a federal appeals court disagreed with the business groups that they have standing to challenge a Biden-era drug price negotiation program.

The opinion from a three-judge panel for the US Court of Appeals for the Sixth Circuit states that a lower federal court was correct in dismissing the lawsuit from the US Chamber in 2024.

The order is another blow for business groups after various courts have ruled in favor of the government program that seeks to lower drug prices by allowing the Medicare agency and drugmakers to ...